1. Home
  2. DNLI vs KFY Comparison

DNLI vs KFY Comparison

Compare DNLI & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

N/A

Current Price

$20.94

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Logo Korn Ferry

KFY

Korn Ferry

N/A

Current Price

$59.54

Market Cap

3.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
DNLI
KFY
Founded
2013
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.4B
IPO Year
2017
1998

Fundamental Metrics

Financial Performance
Metric
DNLI
KFY
Price
$20.94
$59.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
3
Target Price
$30.80
$78.00
AVG Volume (30 Days)
1.6M
461.8K
Earning Date
01-01-0001
03-11-2026
Dividend Yield
N/A
3.23%
EPS Growth
N/A
42.41
EPS
N/A
2.61
Revenue
N/A
$1,819,519,000.00
Revenue This Year
N/A
$5.60
Revenue Next Year
$3,886.00
$4.16
P/E Ratio
N/A
$22.80
Revenue Growth
N/A
12.20
52 Week Low
$10.57
$59.23
52 Week High
$23.77
$78.50

Technical Indicators

Market Signals
Indicator
DNLI
KFY
Relative Strength Index (RSI) 57.99 37.04
Support Level $13.29 N/A
Resistance Level $23.77 $70.29
Average True Range (ATR) 1.20 2.11
MACD -0.05 -0.53
Stochastic Oscillator 69.29 9.17

Price Performance

Historical Comparison
DNLI
KFY

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About KFY Korn Ferry

Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

Share on Social Networks: